Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

OPAL LABORATORIES (PVT) LTD

Private pharmaceutical manufacturer · Karachi · Pakistan

Long-established Karachi pharmaceutical manufacturer with general, cephalosporin and nutraceutical facilities and domestic/export operations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Opal Laboratories (Private) Limited
Company type
Private pharmaceutical manufacturer
Address
LC-41 LITE, Landhi, Karachi, Pakistan
Phone
+92 21 35011047; +92 21 35011046
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000046 Opal Laboratories (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000046 59 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx59public portfolio records represented
REG48unique registrations represented
IDX59indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR55current validated price records
G26generic molecules in indexed catalogue
DF7dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage93%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixOPAL LABORATORIES (PVT) LTDShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/opal-laboratories-pvt-ltdGenerated 23 Sep 2026Anti-infectives34 · 58%Vitamins, minerals & nutrition8 · 14%Respiratory & allergy4 · 7%Cardiovascular4 · 7%Gastrointestinal & hepatology3 · 5%Reproductive & genitourinary2 · 3%CNS & mental health2 · 3%Other therapeutic areas2 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioOPAL LABORATORIES (PVT) LTDDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/opal-laboratories-pvt-ltdGenerated 23 Sep 202659presentationsTablet35 · 59%Suspension8 · 14%Syrup7 · 12%Capsule4 · 7%Cream2 · 3%Sachet2 · 3%Other forms1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionOPAL LABORATORIES (PVT) LTDCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/opal-laboratories-pvt-ltdGenerated 23 Sep 202655comparable productsBelow peer median13 · 24%Near peer median9 · 16%Above peer median33 · 60%Company median price position+7.9%Lowest-price equivalents6Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsOPAL LABORATORIES (PVT) LTDCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/opal-laboratories-pvt-ltdGenerated 23 Sep 2026Zafa Pharmaceutical Laboratories (P…20 shared77% overlapNabiqasim Industries (Pvt) Ltd.,19 shared73% overlapEpharm Laboratories17 shared65% overlapMediate Pharmaceutical Pvt Ltd16 shared62% overlapZephyr Pharmatec (pvt) limited16 shared62% overlapAtco Laboratories Limited15 shared58% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives34 products · 58%
Vitamins, minerals & nutrition8 products · 14%
Respiratory & allergy4 products · 7%
Cardiovascular4 products · 7%
Gastrointestinal & hepatology3 products · 5%
Reproductive & genitourinary2 products · 3%
CNS & mental health2 products · 3%
Fluids & supportive care2 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Vitamins / minerals / hematinics8 products · 14%
Macrolide antibacterials7 products · 12%
First-generation cephalosporins6 products · 10%
Third-generation cephalosporins6 products · 10%
Fluoroquinolone antibacterials5 products · 8%
Antimalarials5 products · 8%
Antihistamines4 products · 7%
Nitroimidazole anti-infectives3 products · 5%
Formulation footprint

Dosage forms

Tablet35 products
Suspension8 products
Syrup7 products
Capsule4 products
Cream2 products
Sachet2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 MURBEXCephalexin 6presentations 125 mg/5 mL, 250 mg, 250 MG/5 mL, 500 mg · Suspension, Tablet #2 VENCEFCefixime 6presentations 100 mg/5 mL, 200 MG, 200 mg/5 mL, 400 mg · Suspension, Tablet, Capsule #3 Z-MACAzithromycin 4presentations 100 mg/5 mL, 200 mg/5 mL, 250 mg, 500 MG · Suspension, Capsule, Tablet #4 FERFIXElemental iron + Folic acid 3presentations 50 mg + 0.35 mg · Syrup, Drops #5 MALTHERArtemether + Lumefantrine 3presentations 20 mg + 120 mg, 40 mg + 240 mg, 80 MG + 480 MG · Tablet #6 VENRITHClarithromycin 3presentations 125 MG/5 mL, 250 mg, 500 mg · Syrup, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1324% of comparable products
Near market median9within ±5% of median
Above market median3360% of comparable products
Lowest-price equivalents6ties included
Company median price position +7.9% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
WATBAL FRUIT 2.6 gSodium chloride · Sachet · 20'S PKR 10.33/sachet-58.4% vs market median WATBAL ORANGE 2.6 gSodium chloride · Sachet · 20'S PKR 10.33/sachet-58.4% vs market median Z-MAC 500 MGAzithromycin · Tablet · 6’S PKR 68.78/tablet-19.0% vs market median VENCEF 200 mg/5 mLCefixime · Suspension · 60ML PKR 11.19/mL-17.0% vs market median FERFIX FA CHEWABLE 100 mgElemental Iron · Chewable tablet · 20'S PKR 13.73/tablet-14.4% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 20shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 19shared generics Epharm Laboratories144 products · 67 generics 17shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 16shared generics Zephyr Pharmatec (pvt) limited85 products · 38 generics 16shared generics Atco Laboratories Limited278 products · 94 generics 15shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers48Distinct registrations among indexed, published, presentation-validated products only
Verified price observations59
Products with a verified price59
Products with multiple price observations0
Source records with multiple versions59
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

48 unique registration(s) · 59 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
ATADINE TABLTS Loratadine 10 mg Tablet 10’S 027675 PKR 268.49 PKR 26.85/tablet 88% above median
DURAMOX Moxifloxacin 400 MG Tablet 5’S 035823 PKR 994.57 PKR 198.91/tablet 8% above median
Excipro Ciprofloxacin 250 mg Tablet 1 X 10’S 017228 PKR 367.99 PKR 36.80/tablet 46% above median
Excipro Ciprofloxacin 500 mg Tablet 1 X 10’S 017229 PKR 647.68 PKR 64.77/tablet 51% above median
FERFIX Elemental iron + Folic acid 50 mg + 0.35 mg Syrup 120ml 048548 PKR 287.58 PKR 2.40/mL 15% above median
FERFIX Elemental iron + Folic acid 50 mg + 0.35 mg Syrup 60ml 048548 PKR 151.36 PKR 2.52/mL 21% above median
FERFIX Elemental iron + Folic acid 50 mg + 0.35 mg Oral drops 15ML 048549 PKR 140.54 PKR 9.37/mL No comparator
FERFIX FA CHEWABLE Elemental Iron 100 mg Chewable tablet 20'S 048547 PKR 274.69 PKR 13.73/tablet 14% below median
FERFIX FA CHEWABLE IRON III HPM COMPLEX Folic acid 100 mg Chewable tablet 10'S 048547 PKR 144.57 PKR 14.46/tablet Near median
FLORID Clomifene citrate 50 mg Tablet 30'S 075806 PKR 1,188.84 PKR 39.63/tablet 6% below median
FLORID Clomifene citrate 50 MG Tablet 10'S 075806 PKR 446.11 PKR 44.61/tablet 7% above median
LEVO-F Levofloxacin 250 mg Tablet 10'S 042371 PKR 516.33 PKR 51.63/tablet 8% above median
LEVO-F Levofloxacin 500 mg Tablet 10'S 042372 PKR 859.17 PKR 85.92/tablet 9% above median
LISINOCARE Lisinopril 10 mg Tablet 10’S 037955 PKR 202.20 PKR 20.22/tablet 23% above median
LISINOCARE Lisinopril 5.4450 mg Tablet 10’S 039349 PKR 113.43 PKR 11.34/tablet No comparator
MACNAZ Miconazole 20 mg/g Cream 25GM 075803 PKR 217.58 PKR 8.70/g 31% above median
MACNAZ Miconazole 20 mg/g Cream 20GM 075803 PKR 177.98 PKR 8.90/g 34% above median
MALTHER Artemether + Lumefantrine 20 mg + 120 mg Tablet 2 X 8’S 039347 PKR 660.90 PKR 41.31/tablet 5% above median
MALTHER Artemether + Lumefantrine 40 mg + 240 mg Tablet 8'S 053372 PKR 545.24 PKR 68.16/tablet 6% above median
MALTHER Artemether + Lumefantrine 80 MG + 480 MG Tablet 6'S 066801 PKR 681.55 PKR 113.59/tablet Near median
MURBEX Cephalexin 250 mg Tablet 16'S 031145 PKR 188.46 PKR 11.78/tablet 8% below median
MURBEX Cephalexin 250 mg Tablet 12'S 031145 PKR 152.83 PKR 12.74/tablet 8% above median
MURBEX Cephalexin 500 mg Tablet 16'S 031146 PKR 340.78 PKR 21.30/tablet 18% below median
MURBEX Cephalexin 500 mg Tablet 12'S 031146 PKR 309.80 PKR 25.82/tablet 21% above median
MURBEX Cephalexin 125 mg/5 mL Suspension 60ML 031147 PKR 105.33 PKR 1.76/mL 6% below median
MURBEX Cephalexin 250 MG/5 mL Suspension 60ML 031148 PKR 183.81 PKR 3.06/mL 7% below median
OEZI Zinc sulfate monohydrate 10 mg Tablet 20'S 067261 PKR 123.92 PKR 6.20/tablet 32% below median
OEZI Zinc sulfate 20 mg Tablet 30'S 067262 PKR 309.80 PKR 10.33/tablet Near median
Opa Hydroxychloroquine 200 mg Tablet 5 x 10'S 105375 PKR 675.31 PKR 13.51/tablet 7% below median
Opa Hydroxychloroquine 200 mg Tablet 3 x 10'S 105375 PKR 405.18 PKR 13.51/tablet 7% below median
OPALAC Lactulose 67 g Syrup 120ML 029311 PKR 305.67 PKR 2.55/mL No comparator
OPOZOL Metronidazole 200 MG Tablet 10 X 10’S 004972 PKR 250.24 PKR 2.50/tablet 17% above median
OPOZOL Metronidazole 400 MG Tablet 10 X 10’S 011601 PKR 363.21 PKR 3.63/tablet 22% above median
OPOZOL Metronidazole (Benzoate) 200 MG/5 mL Suspension 60ML 012039 PKR 69.49 PKR 1.16/mL 18% above median
PRAMEASE Escitalopram 10 mg Tablet 14'S 036323 PKR 818.67 PKR 58.48/tablet 10% above median
PRAMEASE Escitalopram 10 MG Tablet 10'S 036323 PKR 616.47 PKR 61.65/tablet 16% above median
REDULEX Omeprazole 20 mg Capsule 2 X 7'S 027676 PKR 318.06 PKR 22.72/capsule 16% above median
REDULEX Omeprazole 20 mg Capsule 10’S 027676 PKR 227.18 PKR 22.72/capsule 16% above median
SASTOR Amlodipine 5 mg Tablet 20'S 076761 PKR 681.55 PKR 34.08/tablet 214% above median
SASTOR Amlodipine 10 mg Tablet 20'S 076762 PKR 784.82 PKR 39.24/tablet 131% above median
SINEASE Loratadine 5 mg/5 mL Syrup 60ML 030394 PKR 116.11 PKR 1.94/mL 15% above median
SINEASE Loratadine 5 mg/5 mL Syrup 30ML 030394 PKR 53.70 PKR 1.79/mL 6% above median
SINEASE DISP Loratadine 10 mg Tablet 10’S 030396 PKR 154.90 PKR 15.49/tablet 8% above median
TORRSAM Ferrous sulfate + Folic acid 150 mg + 0.5 mg Tablet 3 X 10’S 029308 PKR 67.57 PKR 2.25/tablet 42% above median
VENCEF Cefixime 400 mg Capsule 5’S 032024 PKR 592.04 PKR 118.41/capsule Near median
VENCEF Cefixime 200 mg/5 mL Suspension 60ML 032025 PKR 671.22 PKR 11.19/mL 17% below median
VENCEF Cefixime 200 mg/5 mL Suspension 30ML 032025 PKR 404.32 PKR 13.48/mL Near median
VENCEF Cefixime 200 MG Tablet 10'S 039068 PKR 648.51 PKR 64.85/tablet Near median
VENCEF Cefixime 100 mg/5 mL Suspension 30ML 039354 PKR 330.39 PKR 11.01/mL Near median
VENCEF Cefixime 50 mg/5 mL Syrup 30ML 042165 PKR 165.22 PKR 5.51/mL No comparator
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). OPAL LABORATORIES (PVT) LTD — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/opal-laboratories-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.